Kadcyla, a drug that can offer some women with advanced breast cancer nearly six months of extra life, which was trialled here in the North East, has for now been rejected for use in the NHS, because of its high cost.
A Newcastle doctor whose patients have been involved in the clinical trials is disappointed by the decision.
Dr Mark Verrill, from the Freeman Hospital, say the drug is revolutionary.
More top news
Newcastle United have achieved promotion back to the Premier League, just 348 days after being relegated.
New powers to clamp down on anti-social behaviour in Newcastle have been approved by city councillors.
Cold winds will bring tumbling temperatures and the risk of SNOW.